Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model

about

A bystander cell-based GM-CSF secreting vaccine synergized with a low dose of cyclophosphamide presents therapeutic immune responses against murine hepatocellular carcinoma.Combining low-dose or metronomic chemotherapy with anticancer vaccines: A therapeutic opportunity for lymphomas.

P2860

Q37729647-4D8DAC13-713E-48C8-B2AB-490DD5342B78 Q42734547-76544670-E8C1-443F-B730-F40E4D94D5E1

P2860

Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model

Item

http://www.wikidata.org/entity/Q37727843

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 September 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cyclic adenosine monophosphate ...... sion in a mouse lymphoma model

@en

Cyclic adenosine monophosphate ...... ion in a mouse lymphoma model.

@nl

type

Item

label

Cyclic adenosine monophosphate ...... sion in a mouse lymphoma model

@en

Cyclic adenosine monophosphate ...... ion in a mouse lymphoma model.

@nl

prefLabel

Cyclic adenosine monophosphate ...... sion in a mouse lymphoma model

@en

Cyclic adenosine monophosphate ...... ion in a mouse lymphoma model.

@nl

P1476

Cyclic adenosine monophosphate ...... sion in a mouse lymphoma model

@en

P2093

Ai-Xia Dou

http://www.w3.org/2001/XMLSchema#string

Li-Li Feng

http://www.w3.org/2001/XMLSchema#string

Xiao-Qian Liu

http://www.w3.org/2001/XMLSchema#string

Xin Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Improved systemic delivery of oncolytic reovirus to established tumors using preconditioning with cyclophosphamide-mediated Treg modulation and interleukin-2

The phosphodiesterase PDE4B limits cAMP-associated PI3K/AKT-dependent apoptosis in diffuse large B-cell lymphoma

The adaptor protein EBP50 is important for localization of the protein kinase A-Ezrin complex in T-cells and the immunomodulating effect of cAMP

Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology.

Constitutive reductions in mTOR alter cell size, immune cell development, and antibody production.

CD4+FOXP3+ regulatory T cell depletion by low-dose cyclophosphamide prevents recurrence in patients with large condylomata acuminata after laser therapy.

Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.

In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy.

Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.

cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells

P2888

cmi.2012.34

P304

482-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/CMI.2012.34

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260176109

http://www.w3.org/2001/XMLSchema#string

P698

23000689

http://www.w3.org/2001/XMLSchema#string

P932

4002215

http://www.w3.org/2001/XMLSchema#string

Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model

about

P2860

P2860

Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P932